Clinical Trial

A Multiple Ascending Dose Study of LW402 in Healthy Volunteers

Name: A Multiple Ascending Dose Study of LW402 in Healthy Volunteers — clinical trial record (NCT07546149)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 1

View on ClinicalTrials.gov →

Summary

This Phase 1, double-blind (sponsor open), placebo controlled study will assess the safety, tolerability and pharmacokinetics of multiple doses of LW402 tablets in healthy volunteers.

Trial Details

NCT Number	NCT07546149
Lead Sponsor	Shanghai Longwood Biopharmaceuticals Co., Ltd.
Conditions	Safety Evaluation of Escalating Doses
Enrollment	36 participants
Start Date	2025-10-15
Primary Completion	2025-12-09 (estimated)
Study Completion	2025-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-04-22